High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity-Reference-Cited by-同舟云学术

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

Published:2004-05-10 Issue:1 Volume:34 Page:69-76
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gojo I,Guo C,Sarkodee-Adoo C,Meisenberg B,Fassas A,Rapoport A P,Cottler-Fox M,Heyman M,Takebe N,Tricot G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704529.pdf

Reference17 articles.

1. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97.

2. Attal M, Harousseau JL . Randomized trial experience of the Intergroupe Francophone du Myelome. Semin Hematol 2001; 38: 226–230.

3. Barlogie B, Jagannath S, Desikan KR et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999; 93: 55–65.

4. Barbui AM, Galli M, Dotti G et al. Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma. Br J Haematol 2002; 116: 202–210.

5. Olavarria E, Kanfer EJ . Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells. Curr Opin Hematol 2000; 7: 191–196.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization;Annals of Hematology;2024-01-25

2. Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma;Transfusion and Apheresis Science;2021-10

3. Intermediate-dose cytarabine plus G-CSF as mobilization regimen for newly diagnosed multiple myeloma and heavily pre-treated patients with hematological and non-hematological malignancies;Transfusion and Apheresis Science;2019-06

4. Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era;Clinical Lymphoma Myeloma and Leukemia;2019-04

5. Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT;Clinical oncohematology;2018